Vincerx Pharma, Inc.
VINC
$0.049
-$0.006-10.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.07M | -27.03M | -28.19M | -37.94M | -40.16M |
| Total Depreciation and Amortization | 1.09M | 1.07M | 1.05M | 1.03M | 915.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.04M | 3.45M | 2.23M | 7.68M | 2.98M |
| Change in Net Operating Assets | -178.00K | -5.45M | -3.31M | -5.87M | -4.19M |
| Cash from Operations | -26.13M | -27.97M | -28.23M | -35.10M | -40.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 212.00K | -1.21M | 12.47M | 35.62M | 41.50M |
| Cash from Investing | 212.00K | -1.21M | 12.47M | 35.62M | 41.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.99M | 17.03M | 17.03M | 116.00K | 114.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.99M | 17.03M | 17.03M | 116.00K | 114.00K |
| Foreign Exchange rate Adjustments | 135.00K | 32.00K | -12.00K | 2.00K | -40.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.79M | -12.12M | 1.26M | 633.00K | 1.12M |